Skip to main navigation
Skip to search
Skip to main content
Erasmus University Rotterdam Home
Help & FAQ
Home
Research output
Researchers
Research units
Activities
Prizes
Press/Media
Datasets
Search by expertise, name or affiliation
Erasmus School of Health Policy & Management
Erasmus University Rotterdam
Overview
Fingerprint
Network
Researchers
(361)
Research output
(7690)
Datasets
(151)
Prizes
(27)
Activities
(133)
Press/Media
(32)
Research output
Research output per year
1977
1995
1999
2001
2004
2006
2007
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2024
183982
Citations
5823
Article
612
Chapter
375
Report
269
Doctoral Thesis
611
More
107
Review article
81
Book
75
Case note
60
Comment/Letter to the editor
43
Meeting Abstract
40
Web publication/site
35
Book editing
31
Working paper
26
Editorial
17
Poster
16
Inaugural speech
16
Conference contribution
16
Book/Film/Article review
13
Conference proceeding
9
Other contribution
7
Abstract
6
Paper
4
Short survey
3
Preprint
2
Conference article
1
Foreword/postscript
1
Software
1
Master's Thesis
1
Discussion paper
Research output per year
Research output per year
3 results
Publication Year
(descending)
Publication Year
(ascending)
Title
Type
Filter
Preprint
Search results
2024
Mind the gap! Overcoming the lack of evidence to support the innovation journey of AI in healthcare
Silkens, M.
,
Leusder, M.
, Woznitza, N. & Scarbrough, H.,
10 Jun 2024
, (E-pub ahead of print)
JMIR Publications Inc.
,
20 p.
Research output
:
Working paper
›
Preprint
›
Academic
Open Access
2023
Dynamic Simulation Modeling to Analyze the Impact of Whole Genome Sequencing National Implementation Scenarios in Lung cancer on Time
van de Ven, M., Koffijberg, E.,
Retel, V.
, Van Harten, W. &
IJzerman, M.
,
10 Nov 2023
, (medRxiv : the preprint server for health sciences).
Research output
:
Working paper
›
Preprint
›
Academic
Open Access
File
Lung Cancer
100%
Whole Genome Sequencing
100%
Health Care Cost
50%
Time to Treatment
41%
Diagnosis
33%
27
Downloads (Pure)
Cost-effectiveness of CTC guided chemo- or endocrine therapy in ER+ HER2- metastatic breast cancer – results from a randomized controlled multicenter trial
Berghuis, S., Koffijberg, E., Pouwels, X., Berger, F., Alix-Panabieres, C., Jacob, W., Pierga, J.-Y., Bidard, F.-C. &
IJzerman, M.
,
9 Oct 2023
, (medRxiv : the preprint server for health sciences).
Research output
:
Working paper
›
Preprint
›
Academic
Open Access
File
Hormone Therapy
100%
Circulating Tumor Cell
100%
Metastatic Breast Cancer
100%
Cost-Effectiveness Analysis
100%
Chemotherapy
100%
31
Downloads (Pure)